THE WHAT? The U.S. Food and Drug Administration (FDA) issued a warning about the distribution of counterfeit versions of AbbVie’s Botox, which have been administered for cosmetic purposes across ...

Officials with the California Department of Public Health issued a warning Wednesday to consumers seeking Botox injections ...

Top-notch biotech stock Neurocrine launched higher Tuesday after the company's depression treatment succeeded in a midstage study. The complete response letter for Abeona’s treatment is one of ...

(Adds details on patients, states reporting reactions and background from paragraph 2 onwards) April 23 (Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday alerted ...

(Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday alerted clinicians about risks of counterfeit versions of AbbVie's Botox that were given to consumers for cosmetic ...

“Our supply chain has been infiltrated with counterfeit Botox — historically, presently, and will be in the future,” said ...

(Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) on Tuesday alerted clinicians about risks of counterfeit versions of AbbVie’s Botox that were given to consumers for cosmetic ...

Counterfeit Botox in the U.S. triggers harmful reactions, mimicking botulism symptoms. FDA and CDC investigate, caution against unlicensed sources. Th ...

Following is a summary of current health news briefs. Alzheimer's drug adoption in US slowed by doctors' skepticism Nine months into the U.S. launch of the first drug proven to slow the advance of ...